Connect Hearing, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3115 Western Branch Blvd Ste 101, Chesapeake, VA 23321 Phone: 757-483-0232 Fax: 757-673-4675 |
Megan Butcher Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1019 Chattanooga St, Chesapeake, VA 23322 Phone: 201-655-8838 |
Morgan Magee O'malia, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1987 S Military Hwy, Chesapeake, VA 23320 Phone: 757-722-9961 |
Kathleen Mcmahon, M.S., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 200 Medical Pkwy, Suite 303, Chesapeake, VA 23320 Phone: 757-547-9714 Fax: 757-547-0725 |
Sharon Hooper Minor Audiologist Medicare: Accepting Medicare Assignments Practice Location: 4020 Raintree Rd, Suite C, Chesapeake, VA 23321 Phone: 757-488-2080 Fax: 757-405-3025 |
Dr. Michael William Lemay, AUD, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 500 Independence Pkwy Ste 100, Chesapeake, VA 23320 Phone: 757-547-9714 Fax: 757-547-0725 |
Dr. Fina Marah Young, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1987 S Military Hwy, Chesapeake, VA 23320 Phone: 757-722-9961 |
Pamela B Swartz, AU.D CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 200 Medical Pkwy Ste 303, Chesapeake, VA 23320 Phone: 757-547-9714 Fax: 757-547-0725 |
Paula A Abraham, AU.D CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 200 Medical Pkwy Ste 303, Chesapeake, VA 23320 Phone: 757-547-9714 Fax: 757-547-0725 |
Stephanie Howard, M.A.,CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 500 Independence Parkway, Suite 100, Chesapeake, VA 23320 Phone: 757-547-9714 Fax: 757-547-0725 |
Mr. Michael Louis Pachuilo, M.S., CCC-A Audiologist - Assistive Technology Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1021 Eden Way N, Suite 111, Chesapeake, VA 23320 Phone: 757-547-3560 Fax: 757-547-5053 |
News Archive
BioLineRx, a biopharmaceutical development company, announced today that it has received regulatory approval from the Finnish National Supervisory Authority for Welfare and Health (Valvira) to commence a Phase 1/2 safety trial for BL-7010, for the treatment of celiac disease.
Researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine and Moores UCSD Cancer Center have shown one way in which gliomas, a deadly type of brain tumor, can evade drugs aimed at blocking a key cell signaling protein, epidermal growth factor receptor (EGFR),that is crucial for tumor growth.
The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by reducing inflammation, according to late-breaking results from the CANTOS trial presented today in a Hot Line - LBT Session at ESC Congress1 and published in the NEJM.
Qi Zhang sees himself as a warrior. In his lab at the University of North Carolina at Chapel Hill, he wages war on genetic diseases such as cancer and heart disease on a battlefield measured with single atoms.
SRI International, an independent nonprofit research and development organization, announced today that it has assumed responsibility for further clinical development of the TAS-108 breast cancer program, in cooperation with Taiho Pharmaceuticals Co., Ltd., a leading Japanese pharmaceutical company. Further clinical development will focus on the lead compound's registration for the treatment of tamoxifen and aromatase inhibitor-resistant breast cancers.
› Verified 6 days ago